0.5(top 100%)
impact factor
733(top 20%)
papers
13.4K(top 20%)
citations
53(top 10%)
h-index
0.5(top 100%)
impact factor
771
all documents
13.7K
doc citations
83(top 10%)
g-index

Top Articles

#TitleJournalYearCitations
1Evolution of neuronal changes in the course of Alzheimer’s diseaseJournal of Neural Transmission Supplementum1998404
2Parkinson's Disease Society Brain Bank, London: overview and researchJournal of Neural Transmission Supplementum1993347
3Mechanism of 6-hydroxydopamine neurotoxicityJournal of Neural Transmission Supplementum1997308
4Post mortem studies in Parkinson’s disease — is it possible to detect brain areas for specific symptoms?Journal of Neural Transmission Supplementum1999295
5Neuropathology of Alzheimer’s disease: a critical updateJournal of Neural Transmission Supplementum1998196
6Amantadine and memantine are NMDA receptor antagonists with neuroprotective propertiesJournal of Neural Transmission Supplementum1994153
7Measurement of the dopaminergic degeneration in Parkinson’s disease with [123I]β-CIT and SPECTJournal of Neural Transmission Supplementum1997143
8Sustained efficacy and safety of idebenone in the treatment of Alzheimer’s disease: update on a 2-year double-blind multicentre studyJournal of Neural Transmission Supplementum1998137
9The calcium ion and cell deathJournal of Neural Transmission Supplementum1994126
10Recent developments in the pathology of Parkinson’s diseaseJournal of Neural Transmission Supplementum2002122
11Cytokines in Parkinson's diseaseJournal of Neural Transmission Supplementum2000122
12Neuronal vulnerability in Parkinson’s diseaseJournal of Neural Transmission Supplementum1997118
13Evolution of Alzheimer’s disease related cortical lesionsJournal of Neural Transmission Supplementum1998115
14Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tanglesJournal of Neural Transmission Supplementum1998112
15Neurotrophic factors and Alzheimer’s disease: are we focusing on the wrong molecule?Journal of Neural Transmission Supplementum2002108
16Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disordersJournal of Neural Transmission Supplementum1994108
17General aspects of neurodegenerationJournal of Neural Transmission Supplementum2003102
18Nigral and extranigral pathology in Parkinson's diseaseJournal of Neural Transmission Supplementum199598
19Clinical features of frontal lobe dementia in comparison to Alzheimer’s diseaseJournal of Neural Transmission Supplementum199697
20Free radicals in Alzheimer’s diseaseJournal of Neural Transmission Supplementum199896
21The prognosis of mild cognitive impairment in the elderlyJournal of Neural Transmission Supplementum199890
22Prevalence of mild cognitive impairment in an elderly community sampleJournal of Neural Transmission Supplementum199888
23Increased striatal dopamine production from L-DOPA following selective inhibition of monoamine oxidase B by R(+)-N-propargyl-1-aminoindan (rasagiline) in the monkeyJournal of Neural Transmission Supplementum199886
24Animal models of Parkinson’s disease in rodents induced by toxins: an updateJournal of Neural Transmission Supplementum200384
25The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescenceJournal of Neural Transmission Supplementum198381
26Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptidesJournal of Neural Transmission Supplementum198380
27The N-methyl-D-aspartate antagonist memantine retards progression of Huntington’s diseaseJournal of Neural Transmission Supplementum200479
28On tyramine, food, beverages and the reversible MAO inhibitor moclobemideJournal of Neural Transmission Supplementum198879
29Long-term stabilizing effect of cholinesterase inhibitors in the therapy of Alzheimer’ diseaseJournal of Neural Transmission Supplementum200278
30The spectrum of age-associated brain abnormalities: their measurement and histopathological correlatesJournal of Neural Transmission Supplementum199878
31The neuropathological diagnosis of Alzheimer diseaseJournal of Neural Transmission Supplementum199876
32Stereotaxic intrastriatal implantation of human retinal pigment epithelial (hRPE) cells attached to gelatin microcarriers: a potential new cell therapy for Parkinson’s diseaseJournal of Neural Transmission Supplementum200374
33Effects of N-propargyl-1-(R)aminoindan (rasagiline) in models of motor and cognition disordersJournal of Neural Transmission Supplementum199873
34Mild cognitive impairment — an early stage of Alzheimer’s disease?Journal of Neural Transmission Supplementum199873
35The neuropathology of progressive supranuclear palsyJournal of Neural Transmission Supplementum199470
36Positron emission tomography for diagnosis of Alzheimer’s disease and vascular dementiaJournal of Neural Transmission Supplementum199867
37The MNB/DYRK1A protein kinase: Genetic and biochemical propertiesJournal of Neural Transmission Supplementum200367
38Vascular progressive supranuclear palsyJournal of Neural Transmission Supplementum199465
39Mechanisms of cell death in Alzheimer disease — immunopathologyJournal of Neural Transmission Supplementum199865
40The cytoskeleton in Alzheimer diseaseJournal of Neural Transmission Supplementum199865
41Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetesJournal of Neural Transmission Supplementum199863
42The MNB/DYRK1A protein kinase: Neurobiological functions and Down syndrome implicationsJournal of Neural Transmission Supplementum200363
43The "gene dosage effect" hypothesis versus the "amplified developmental instability" hypothesis in Down syndromeJournal of Neural Transmission Supplementum199963
44Morphological substrates of dementia in parkinsonism A critical updateJournal of Neural Transmission Supplementum199761
45Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in Diffuse Lewy body disease, Pick’s disease, and Corticobasal DegenerationJournal of Neural Transmission Supplementum199658
46Chemical evidence for 6-hydroxydopamine to be an endogenous toxic factor in the pathogenesis of Parkinson's diseaseJournal of Neural Transmission Supplementum199557
47Neurotrophic activities and therapeutic experience with a brain derived peptide preparationJournal of Neural Transmission Supplementum199856
48Cognitive correlates of cerebral white matter changesJournal of Neural Transmission Supplementum199855
49(R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase BJournal of Neural Transmission Supplementum199855
50Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animalsJournal of Neural Transmission Supplementum198655